Sign Out
Oral administration: Disorders related to progesterone insufficiency and in particular: Primary and secondary amenorrhea; Premenstrual disorder; Bleeding due to fibroma; Adjunctive use with oestrogen in post-menopausal women.
Vaginal administration: To help pregnancy, in particular: Luteal phase support during in vitro fertilisation (IVF) cycles; Threatened miscarriage or prevention of habitual miscarriage due to luteal phase deficiency up to the 12th week of pregnancy; Preterm labour.
Continue with Google